Comparison Actuate Therapeutics (ACTU) with Competitors
Actuate Therapeutics (ACTU) industry is Biotechnology.
Free Cash Flow Yield
ACTU-48.07%
Industry-1.75%
Upside-46.32%
P/E
ACTU-1.80
Industry-20.52
Upside+1871.90%
P/B
ACTU10.87
Industry5.15
Upside+111.20%